8-KRegulation FD

CENTENE CORP 8-K Report, Regulation FD Disclosure (Sep 10, 2024)

Filed September 10, 2024For Securities:CNC

Summary

Centene Corporation (CNC) filed an 8-K on September 10, 2024, to disclose information from an investor meeting. The key takeaway for investors is the reaffirmation of the company's full-year 2024 adjusted diluted earnings per share (EPS) guidance of greater than $6.80. This indicates management's confidence in achieving its previously stated financial targets for the year. The filing also reiterates a shift in EPS realization from the third quarter (Q3) to the fourth quarter (Q4) of 2024, with Q3 adjusted diluted EPS projected to be between $1.31 and $1.41. The company further noted positive progress in improving its Medicare Advantage Stars program performance, a key area for future growth and revenue enhancement within its government-backed health insurance offerings.

Key Highlights

  • 1Reaffirms 2024 full-year adjusted diluted EPS guidance of greater than $6.80.
  • 2Projects Q3 2024 adjusted diluted EPS between $1.31 and $1.41.
  • 3Indicates a shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4 2024.
  • 4Reiterates continued progress in improving Medicare Advantage Stars program performance.
  • 5Provides non-GAAP financial measures for a clearer view of ongoing operations and performance trends.
  • 6Emphasizes that non-GAAP measures may differ from those used by other companies and should be viewed alongside GAAP information.

Frequently Asked Questions

Centene has reaffirmed its full-year 2024 adjusted diluted EPS guidance of greater than $6.80. This guidance indicates management's continued confidence in the company's financial performance for the remainder of the year.

Centene expects a shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4 2024. Consequently, the projected adjusted diluted EPS for Q3 is between $1.31 and $1.41, with the remaining portion of the full-year EPS expected to be realized in Q4.

The company reiterated that it remains encouraged by the progress made in improving its Medicare Advantage Stars program performance. Strong Stars ratings are crucial for revenue and future growth within the Medicare Advantage segment.

Centene provides non-GAAP financial measures, such as adjusted diluted EPS, because it believes these figures help investors assess the ongoing nature of its operations and measure performance more consistently across periods. These measures are also used internally for performance evaluation and planning.